405103-68-6 Usage
General Description
2-(Chloromethyl)-6-methoxypyridine is an organic compound that belongs to the class of chemicals known as organochlorides and is a derivative of pyridine. It is characterized by its chloromethyl and methoxy functional groups attached to a pyridine ring. This chemical is primarily used in pharmaceutical applications and in various chemical reactions as a building block or intermediate due to its reactivity. Its physical properties such as its molecular weight, melting point, and any toxicological information can be found on Material Safety Data Sheets (MSDS), as it is standard for all industrial chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 405103-68-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,5,1,0 and 3 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 405103-68:
(8*4)+(7*0)+(6*5)+(5*1)+(4*0)+(3*3)+(2*6)+(1*8)=96
96 % 10 = 6
So 405103-68-6 is a valid CAS Registry Number.
InChI:InChI=1/C7H8ClNO/c1-10-7-4-2-3-6(5-8)9-7/h2-4H,5H2,1H3
405103-68-6Relevant articles and documents
FUSED PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY ON FMS KINASES
-
, (2014/01/17)
Disclosed are a fused pyrimidine derivative of formula (I), and a pharmaceutically acceptable salt, stereoisomer, hydrate and solvate thereof, which have an excellent inhibitory activity on FMS kinases, and a pharmaceutical composition comprising the same is effective in preventing or treating diseases caused by abnormal activation of FMS kinases such as immunologic diseases, metabolic diseases, inflammatory diseases, cancers and tumors.
IMIDAZOTRIAZINONE COMPOUNDS
-
, (2012/04/10)
The present invention provides imidazotriazinone compounds which are inhibitors of phosphodiesterase 9. The present invention further provides processes, pharmaceutical compositions, pharmaceutical preparations and pharmaceutical use of the compounds in the treatment of PDE9 associated diseases or disorders in mammals, including CNS or neurodegeneration disorder.
